BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1057@pharmaconomics
DTSTAMP:20260707T033942Z
DTSTART;VALUE=DATE:20260610
DTEND;VALUE=DATE:20260611
SUMMARY:HUMA Phase 3 — ATEV
DESCRIPTION:Phase 3 trial results for ATEV in dialysis access are due Jun 10\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1818382/000110465926072382/tm2617224d1_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/1057
URL:https://pharmaconomics.com/e/1057
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:HUMA catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR